SEARCH

UPCOMING LIVE SEMINARS
 






Worldwide Orphan Drug Designation Applications and Requirements March 2012

Mar 6, 2012
Order the DVD of this seminar

Course Description

Globally, there is a need for orphan drug research, development, and approval for underserved patient populations who have diseases that affect very few individuals. While this patient population has been largely ignored, some pharmaceutical companies have built their research pipeline around these patients. Receiving orphan drug designation and approval confers many benefits to the developer to compensate for the development costs of the drug. This web seminar will explore which countries allow orphan drug designations, the application requirements, population limits and how to support this number, how the applications are the same, who to submit the application to, if and when the application can be changed, and how it needs to be supported over the development process.

VideoPreview


Learning Objectives

  • Identify the countries that have orphan drug designations
  • Identify, on a global basis, the differences and similarities of these applications (and how to re-use the information), including differences in population requirements
  • Discuss the importance of the indication chosen for designation, and how this ultimately affects the final label and how this can differ among countries
  • Examine the most difficult sections of the applications and mitigate agency concerns
  • Discuss the benefits of orphan designation
  • Describe how orphan drug indications and applications can be modified
  • Describe the timing of the application in the drug development process

Who Should Attend

  • Individuals who want an introduction to the orphan drug designation on a global scale
  • Regulatory Affairs Professionals
  • Clinical Research Professionals
  • Research and Development Professionals
  • Project Managers

Instructor

Meredith Brown-Tuttle, R.A.C. 

Click here for complete trainer biographies 


Hold this course at your company!
 For more information, contact Naila Ganatra at (215) 413-2471.
 

 

 

 

FOLLOW US ON: 

LinkedIn twitter Facebook 


On-Demand GCP Refresher Training 

Too busy to attend a course? Our newly-released GCP eLearning course may be your solution!
For details on our scenario-based practical GCP application on-demand course, click here.


GCP for Investigators
 

Barnett’s scenario-based eLearning course is designed with the busy Principal Investigator in mind.  Based on real-life scenarios encountered by investigative site teams, this highly focused 7-module GCP training is designed to ensure comprehensive understanding of the key components of GCP.

For more details on this scenario-based eGCP program for investigators please click here. 


BARNETT CATALOG The Barnett Catalogue is your comprehensive guide to the myriad live, web, and custom training opportunities offered throughout the year. 

Jan - July 2014 Edition

Winter CatalogDownload Today!  

Blended Curriculum Path for the CRA, CRC, and Project Manager

BCP Cover

Download Today! 

 

 

 


 

DVD IconWEB SEMINAR ARCHIVE 

 View Catalog of Offerings   

New Titles added every month! 
Course Alumni Save 50% 


Live SeminarLIVE SEMINARS

Monitoring Clinical Drug Studies: Intermediate 

Informed Consent Content & Process Requirements for Biobanking Studies 

Auditing Techniques for Clinical Research Professionals 


Web SeminarWEB SEMINARS

10-Week CRA & CRC Beginner Program  

Trial Master File (TMF) for Sponsors: Set-Up and Maintenance 

Use of Notes to File in Clinical Trial Essential Documentation 

10-Week Clinical Research Associate (CRA) On-Boarding Program  


PublicationsPUBLICATIONS

2012 GCP Question & Answer Guide Print Edition 

2012 Good Clinical Practice Question & Answer Guide Electronic Edition 

CFR/ICH GCP Reference Guide 2012 (Spiral Bound) 

CFR/ICH GCP Reference Guide 2012 (Perfect Bound) 

PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2012/2013 (Hard Copy)